Importantly, mice co-treated with BPF showed strongly reduced steatosis compared to CAF mice, lower blood glucose and triglyceride levels, stimulation of hepatic autophagy, and a reduced Acly gene and protein expression, followed by a more than doubled and tripled production of total SCFAs and butyric acid, respectively. This evidence concerns the gene ACLY and steatosis.